Leadership
Our executive team
Neal A. Patel
Chief Executive Officer
Under his leadership, Elixia’s total enterprise value has more than quadrupled, the number of employees tripled and the company has received numerous accolades for its work across several therapeutic focuses.
Jim F. Crissy
Chief Operating Officer
In his role of COO for Elixia, Jim provides strategic direction and operational oversight to a diverse and unique system of logistics that reflects the disruptive nature of Elixia’s forward approach to clinical trials.
Sam Searcy
Chief Commercial Officer
Sam is an industry veteran who brings access to a professional network of the top CROs and pharma companies. Elixia’s disruptive model is fueled by his expertise in aligning therapeutic knowledge to client needs.
Harry Alcorn
Chief Scientific Officer
Harry masterfully orchestrates the fusion of operational strategy and scientific innovation with deep-rooted industry expertise. His command of our Early Phase Clinical Trials Division underpins Elixia’s leadership in niche-focused clinical trials.
Jennifer L. Yevoli
General Counsel
As General Counsel, Jennifer advises Elixia on a wide range of corporate, regulatory, contracting, and business issues and heads compliance and corporate integrity efforts across the organization.
Management Team
Sahil Mehta
VP of Strategic Operations
Dalia Vrooman
Director of Patient Engagement and Inclusion
Dolly Rivera
VP of Site Network Advancement
Isabel Castano
Head of Quality Assurance Division
Elisabeth Rivera
Trial Excellence and Site Success